P53 fusion protein and application thereof
A fusion protein and protein technology, applied in the P53 fusion protein and application fields, can solve problems such as not yet produced
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0119] Example 1: Production of tetrameric p53 fusion proteins in Escherichia coli and identification of the produced p53 fusion proteins Certainly
[0120] Candidate protein drugs based on p53 should be wild-type to reduce immunogenicity, tetramer to improve drug efficacy, and need to be able to enter the targeted cancer cells. Prior to this invention, all attempts to produce wild-type, full-length, tetrameric p53 without chemical cross-modification were unsuccessful. As far as protein therapeutics are concerned, there are several reasons for isolating stable p53 tetramers. First, the active form of p53 is a tetramer. The p53 monomer binds DNA in a cooperative manner, and the binding force of p53 to DNA increases up to 100-fold after forming a tetramer (McLure, KG and Lee, PW 1998 EMBO J 17: 3342-3350). Second, tetramerization is also important for protein-protein interactions, and tetramerization regulates the binding of some proteins to p53. The tetramer structure al...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com